The COVID-19 pandemic has plunged the global community into a position of universal confusion. Not a single country, including Russia, was fully equipped for this new challenge. A business forced to survive non-working days while maintaining employee benefits was in a difficult situation.
The ExoAtlant company, a spin-off of the portfolio company of the RVC ExoAtlet Biofund portfolio, tested an industrial exoskeleton jointly with the “Scientific Research Institute of Occupational Medicine named after Academician NF. Izmerov.” The study results showed the safety and effectiveness of the development in those areas of production where physical labor associated with lifting and holding weights is used.
In 2019, the Russian venture capital market grew in volume: According to DSight and E&Y, start-up investments exceeded $868 million. However, in 2020, the industry is likely to decline due to the pandemic, which put many business processes on a forced pause, and investment activity also decreased significantly. How can a start-up survive in such conditions?
The Ivix company, established in mid-2012, specializes in the development of an innovative drug based on the signal peptide BP101 — a modulator of disorders of the limbic-reticular complex to stimulate female reproductive function.
Russian Venture Company, which supervises the development of the Competence Centers of the National Technological Initiative in the status of an operator, sums up the results of the first one and a half years of work of structures that were created to accelerate Russia's entry into the technology markets of the future.
Russian Venture Company (RVC) plans to introduce a technology entrepreneurship course in Russian schools in the fall of 2020. The company sent a letter of invitation to the Russian Ministry of Education, RVC said.
The innovative industry also suffered from the crisis associated with COVID – 19: many start-ups were at risk. But there are those who managed to reformat their business in time for current needs. Ekaterina Petrova, Director of GenerationS Corporate Accelerator, spoke about successful examples from its practice.
We are in Dsight analyzed the market for corporate accelerators and hackathons for 2019. Over the past year, corporations have conducted more than 40 acceleration programs and 10 hackathons while the total cost of these activities amounted to about 800 million.
The technology business sees the crisis as not only a threat, but also an opportunity for growth. About a third of companies plan expansion — for example, projects in the field of medicine and logistics. Alexander Povalko, CEO of Russian Venture Company, told Rossiyskaya Gazeta about support measures that will compensate for some problems that have arisen and will help to support the expansion of companies.
With the resumption of the educational process in schools, the media spread information that distance learning systems could not withstand the load due to multiple increases in the number of users. RVC conducted a situation analysis to assess the extent and possible consequences of what is happening.
Organizers of the accelerator of the State Transport Leasing Company (GTLK), created on the basis of GenerationS platform of Russian Venture Company selected to support 11 technological start-ups developing new technologies in various fields of the transport industry. This was announced on Tuesday by the press service of RVC.
The creation of a fund of funds with the participation of state corporations will significantly increase the volume of venture capital in Russia, the Head of Russian Venture Company (RVC) Alexander Povalko told RIA Novosti.
Researchers at the NTI Competence Centre at the Institute of Bioorganic Chemistry (IBCh RAS) named after the RAS Academicians M.M. Shemyakin and Yu. A. Ovchinnikov RAS together with colleagues from Moscow State University named after M.V. Lomonosov created a drug designed to treat ophthalmic complications in patients with diabetes.